Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-invasive Evaluation of Liver Fibrosis, Steatosis, and Nonalcoholic Steatohepatitis in Biopsy-Proven NAFLD Patients

NCT03725631 is registered in ClinicalTrials.gov with Korea University Guro Hospital as lead sponsor.

NCT NCT03725631
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03725631 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-invasive Evaluation of Liver Fibrosis, Steatosis, and Nonalcoholic Steatohepatitis in Biopsy-Proven NAFLD Patients
Lead sponsor
Korea University Guro Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
September 1, 2016
Completion date
August 31, 2019
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nonalcoholic fatty liver, nonalcoholic steatohepatitis